Skip to main content
2022 PRIM&R Annual Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Reg Required
Pre-Reg Required
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
Additional Fee
Additional Fee
CPIA Icon
CPIA Icon
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Deep Dive Series
Deep Dive Series
Networking Series
Networking Series
Workshop Series
Workshop Series
Vendor Insight Series
Vendor Insight Series
Thought Leader Series
Thought Leader Series
Pillars Icon
Pillars Icon
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
New for 2020
New for 2020
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back

2022 PRIM&R Annual Conference

Pharma/Biotech Perspectives

Research Involving Data and Biospecimens

B01 - May I Borrow a Tissue? Secondary Use of Biological Samples

Monday, December 12, 2022
1:30 PM – 2:30 PM ET
Location: Livestreamed
Livestreaming Session Icon CIP Accredited Human Subjects Research Deep Dive Series
The use of de-identified biological samples is a key element for treatment and diagnostic development. However, issues remain around consent and secondary use of such tissues. These issues will become even more salient as the sophistication of methodologies and technologies for re-identification of tissues grows. This session will discuss current issues in the use of biological samples in clinical research, including consent (what is in it, what should be in it), de-identification and re-identification considerations, and ethical issues surrounding secondary use of tissues.

Learning Objectives:

  • Discuss what should be in the consent and protocol and what to do if the consent is silent
  • Review what bioethics considerations de-identification/anonymization do and do not address
  • Share and discuss best practices for managing secondary use